Page 86 - Abt News Today

Ipswich Investment Management Co. Inc. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,460 shares of the healthcare product maker’s stock after buying an additional 186 shares […]

Fulcrum Capital LLC cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,522 shares of the healthcare product maker’s stock after selling 2,315 shares during the quarter. Abbott Laboratories accounts […]

Arcblock (ABT) traded down 10.3% against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on October 8th. Arcblock has a market cap of $7.11 million and $93,334.22 worth of Arcblock was traded on exchanges in the last 24 hours. Over the last week, Arcblock has traded 16.1% lower against the […]

StockNews.com assumed coverage on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a report published on Thursday. The firm issued a buy rating on the healthcare product maker’s stock. A number of other brokerages also recently commented on ABT. Wolfe Research upgraded Abbott Laboratories from an underperform rating to a peer perform rating in […]

Arcataur Capital Management LLC acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 6,864 shares of the healthcare product maker’s stock, valued at approximately $748,000. A number of other hedge funds also […]

Mountain Pacific Investment Advisers Inc. ID reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,790 shares of the healthcare product maker’s stock after selling 299 shares during the […]

Field & Main Bank lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,145 shares of the healthcare product maker’s stock after selling 280 shares during the period. […]

Arcataur Capital Management LLC purchased a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 6,864 shares of the healthcare product maker’s stock, valued at approximately $748,000. Other hedge funds have also modified their holdings […]

Aaron Wealth Advisors LLC lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 9.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,811 shares of the healthcare product maker’s stock after purchasing an additional 507 shares during the period. […]

Arlington Partners LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 132.3% in the second quarter, Holdings Channel.com reports. The firm owned 3,113 shares of the healthcare product maker’s stock after purchasing an additional 1,773 shares during the period. Arlington Partners LLC’s holdings in Abbott Laboratories were worth $339,000 at the end […]